Found: 13
Select item for more details and to access through your institution.
A VLP-based vaccine against interleukin-1α protects mice from atherosclerosis.
- Published in:
- European Journal of Immunology, 2013, v. 43, n. 3, p. 716, doi. 10.1002/eji.201242687
- By:
- Publication type:
- Article
Virus-Like Particles as a Modular System for Novel Vaccines.
- Published in:
- Intervirology, 2002, v. 45, n. 4-6, p. 212, doi. 10.1159/000067912
- By:
- Publication type:
- Article
Reply to 'Blood pressure vaccine shot down by safety concerns'.
- Published in:
- 2006
- By:
- Publication type:
- Letter
O1-06-01: Immunization with Aβ1-6 coupled to the virus-like particle Qβ (CAD106) efficiently removes β-amyloid without inducing Aβ-reactive T-cells
- Published in:
- 2006
- By:
- Publication type:
- Abstract
O1-06-01: Immunization with Aβ1-6 coupled to the virus-like particle Qβ (CAD106) efficiently removes β-amyloid without inducing Aβ-reactive T-cells
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Versatile Virus-Like Particle Carrier for Epitope Based Vaccines.
- Published in:
- PLoS ONE, 2010, v. 5, n. 3, p. 1, doi. 10.1371/journal.pone.0009809
- By:
- Publication type:
- Article
Prediction of polyspecificity from antibody sequence data by machine learning.
- Published in:
- Frontiers in Bioinformatics, 2024, p. 1, doi. 10.3389/fbinf.2023.1286883
- By:
- Publication type:
- Article
Combined Inhibition of Tumor Necrosis Factor α and Interleukin-17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Combined Inhibition of Tumor Necrosis Factor α and Interleukin-17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 1, p. 51, doi. 10.1002/art.38896
- By:
- Publication type:
- Article
The Evolving Landscape of Neuroscience Therapeutics: an Interplay of Multiple Modalities.
- Published in:
- Chimia, 2024, v. 78, n. 1/2, p. 62, doi. 10.2533/chimia.2024.62
- By:
- Publication type:
- Article
Structural analysis of mycobacterial and murine hsp60 epitopes in complex with the class I MHC molecule H-2D<sup>b</sup>
- Published in:
- FEBS Letters, 2003, v. 543, n. 1-3, p. 11, doi. 10.1016/S0014-5793(03)00325-9
- By:
- Publication type:
- Article
Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particles.
- Published in:
- European Journal of Immunology, 2005, v. 35, n. 3, p. 816, doi. 10.1002/eji.200425755
- By:
- Publication type:
- Article
The Second-Generation Active Aβ Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects.
- Published in:
- Journal of Neuroscience, 2011, v. 31, n. 25, p. 9323, doi. 10.1523/JNEUROSCI.0293-11.2011
- By:
- Publication type:
- Article